Author's Reply to Trechot: "Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"
Pierre-Louis ToutainPeggy GandiaJean-Louis MontastrucAlain Bousquet-MélouPeter LeesAude A FerranPierre-Louis ToutainPublished in: Clinical pharmacokinetics (2020)